For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034.
How has the surface plasmon resonance grown historically, and what trends indicate future expansion?
The surface plasmon resonance market size has grown rapidly in recent years. It will grow from $1.19 billion in 2024 to $1.33 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to increasing advances in biotechnology, increasing demand for drug discovery and development, rising applications in clinical diagnostics, growing emphasis on protein interaction studies, and increasing academic research funding.
The surface plasmon resonance market size is expected to see rapid growth in the next few years. It will grow to $2.07 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to rising demand for personalized medicine, increasing applications in food safety testing, growing focus on biomarker discovery, expanding use in environmental monitoring, and increasing adoption in the agricultural biotechnology sector. Major trends in the forecast period include demand for label-free detection technologies, adoption of personalized medicine, advancements in nanotechnology, development of portable and miniaturized SPR systems, and integration with artificial intelligence for data analysis.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20655&type=smp
#Which key factors are driving the expansion of the surface plasmon resonance industry?
The increasing adoption of personalized medicine is expected to propel the growth of the surface plasmon resonance market going forward. Personalized medicine is a tailored approach to healthcare that uses an individual’s genetic, environmental, and lifestyle factors to design customized treatment and prevention strategies. The increasing adoption of personalized medicine is driven by advancements in genomics, the rise of targeted therapies, and the demand for more precise and effective treatments. Surface plasmon resonance helps in personalized medicine by enabling the real-time analysis of biomolecular interactions, helping to identify specific biomarkers, and optimizing drug therapies tailored to individual patients. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and health care organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from 6 in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the increasing adoption of personalized medicine drives the growth of the surface plasmon resonance market.
How is the surface plasmon resonance market segmented by product, application, and end-user?
The surface plasmon resonance market covered in this report is segmented –
1) By Product Type: Imaging System, Sensor System, Reagents
2) By Technology: Prism-Based Surface Plasmon Resonance (SPR), Grating-Based Surface Plasmon Resonance (SPR), Other Technologies
3) By Application: Drug Discovery, Drug Formulation, Controlled Drug Release, Drug Cell Interaction, Material Science, Biosensors
4) By End-User: Academic And Research Institutes, Food And Beverage Industry, Biopharmaceutical Companies, Contract Research Organizations (CROs), Other End-Users
Subsegments:
1) By Imaging System: 2D Imaging Systems, 3D Imaging Systems, High-Resolution Imaging Systems
2) By Sensor System: Optical Sensor Systems, Portable Sensor Systems, Multi-channel Sensor Systems
3) By Reagents: Binding Reagents, Sample Preparation Reagents, Stabilizing Reagents
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/surface-plasmon-resonance-global-market-report
Which major trends are influencing the growth of the surface plasmon resonance industry?
Major companies operating in the surface plasmon resonance market are developing advanced biomolecular analysis technologies, such as injection technology, to eliminate the need for multiple dilution series. The injection technology simplifies biomolecular interaction analysis by merging sample dilution and injection into one step, expediting data acquisition in surface plasmon resonance (SPR) with rapid, single-injection kinetics and affinity measurements. For instance, in April 2022, Sartorius AG, a Germany-based pharmaceutical and laboratory equipment company, launched the Octet SF3, a next-generation surface plasmon resonance instrument tailored for high-throughput, label-free biomolecular interaction analysis. It’s ideal for both frequent and occasional users due to its robust, low-maintenance design. The innovative OneStep and NeXtStep Gradient Injection technologies enable faster, high-quality kinetics and affinity data collection, significantly outpacing traditional methods. It is designed to meet the growing global demand for antibody fragment characterization, vaccine research, and biologics discovery.
Which leading companies are dominating the surface plasmon resonance market landscape?
Major companies operating in the surface plasmon resonance market are GE HealthCare Technologies Inc., Sartorius AG, Cytiva, Bio-Rad Laboratories Inc., Bruker Corporation, HORIBA Ltd., Quanterix Corporation, Jubilant Biosys Limited, Quantum Design Inc., Reichert Inc., NanoSPR Devices, Creative BioMart Inc., Biocompare, Carterra Inc., NICOYA AB, Biosensing Instrument Inc., Plexera LLC, Insplorion AB, BioNavis Ltd., Affinité Instruments, IBIS Technologies B.V., Bioptix Inc
Which geographic areas are expected to offer the highest growth opportunities in thesurface plasmon resonance market?
North America was the largest region in the surface plasmon resonance market in 2024. The regions covered in the surface plasmon resonance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Surface Plasmon Resonance Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20655
Need Customized Data On Surface Plasmon Resonance Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=20655&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
